Stem cell infusions are minimally invasive, typically via intravenous administration or direct intraspinal injection in specialist centres. Immediate post-procedure recovery spans 24–48 hours; mild fever, temporary irritability, or sleep disruption may occur. Serious adverse events are rare but include infection or allergic reaction. No prolonged hospitalisation is required. Children resume normal activities within days. Concomitant physiotherapy, occupational therapy, and education continue during treatment, making recovery intervals indistinct from routine care.
Two completed trials and one recruiting study form the current evidence base. Early-phase research focuses on safety in children aged 2–8 years with non-progressive intellectual disability. Published case series report modest improvements in adaptive behaviour and gross motor milestones over 6–12 months post-infusion. Functional MRI in a small cohort suggested increased activation in key learning circuits. No randomised controlled trials have been completed; comparisons are limited to historical natural history data. Effect magnitude remains unclear; blinded, sham-controlled designs are absent, limiting causal inference.
Sunt un candidat? → · Developmental Cognitive Delay: full overview → · Cost Întârziere Cognitivă a Dezvoltării → · Cost →
Revizuit medical de echipa editorială a StemCellAtlas cu Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită